Literature DB >> 16786156

Heterozygous Thr 135 Ala polymorphism at leucine-rich repeat (LRR) in genomic DNA of toll-like receptor 4 in patients with poorly-differentiated gastric adenocarcinomas.

Tadashi Ohara1, Tetsuo Morishita, Hidekazu Suzuki, Toshifumi Hibi.   

Abstract

The genomic DNA of toll-like receptor (TLR) 2, TLR4, radioprotective 105, TLR6, and TLR9 were examined for mutations in 48 patients with gastric cancer. Of these, 22 had well-differentiated and 20 had poorly-differentiated adenocarcinomas, the latter group including 10 with signet ring cell carcinomas. The remaining 6 had gastric adenomas. Ten healthy volunteers with no family history of malignant diseases served as controls. DNA was extracted from peripheral blood and subjected to electrophoresis using PCR oligonucleotide primers. The resultant gel was analyzed with a DNA sequencer. None of the healthy volunteers, patients with gastric adenomas or those with well-differentiated gastric adenocarcinomas showed mutations. However, 8 of the 20 with poorly-differentiated gastric adenocarcinoma showed heterozygosity at the 135th position of the amino acid sequence of TLR4, and a mutation from threonine to alanine was found at this site. Analysis of the entire available amino acid sequence of TLR4 revealed that this mutation occurred at a leucine-rich repeat corresponding to one of its extracellular components. This suggests a disturbance in the protein phosphorylation reaction of TLR4, and that this disturbance is related to the development of poorly-differentiated gastric adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16786156

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  14 in total

Review 1.  Toll-like receptors and cancer.

Authors:  Seth Rakoff-Nahoum; Ruslan Medzhitov
Journal:  Nat Rev Cancer       Date:  2008-12-04       Impact factor: 60.716

Review 2.  TLR4 Polymorphisms and Expression in Solid Cancers.

Authors:  Nilesh Pandey; Alex Chauhan; Neeraj Jain
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

Review 3.  Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?

Authors:  Li Yu; Liantang Wang; Shangwu Chen
Journal:  Cell Mol Life Sci       Date:  2011-11-03       Impact factor: 9.261

Review 4.  Role of Toll-like receptors in gastrointestinal malignancies.

Authors:  M Fukata; M T Abreu
Journal:  Oncogene       Date:  2008-01-07       Impact factor: 9.867

Review 5.  Pathogen recognition receptors, cancer and inflammation in the gut.

Authors:  Masayuki Fukata; Maria T Abreu
Journal:  Curr Opin Pharmacol       Date:  2009-10-12       Impact factor: 5.547

6.  Deficiency of the myeloid differentiation primary response molecule MyD88 leads to an early and rapid development of Helicobacter-induced gastric malignancy.

Authors:  Anirban Banerjee; Soracha Thamphiwatana; Ellese M Carmona; Barry Rickman; Kelly S Doran; Marygorret Obonyo
Journal:  Infect Immun       Date:  2013-10-28       Impact factor: 3.441

7.  MiR-216a exerts tumor-suppressing functions in renal cell carcinoma by targeting TLR4.

Authors:  Wanhui Wang; Enyang Zhao; Yang Yu; Bo Geng; Wenfu Zhang; Xuedong Li
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

8.  Novel mutations in TLR genes cause hyporesponsiveness to Mycobacterium avium subsp. paratuberculosis infection.

Authors:  Mangesh R Bhide; Rastislav Mucha; Ivan Mikula; Lucia Kisova; Rostislav Skrabana; Michal Novak; Ivan Mikula
Journal:  BMC Genet       Date:  2009-05-26       Impact factor: 2.797

9.  A 5'-flanking region polymorphism in toll-like receptor 4 is associated with gastric cancer in a Chinese population.

Authors:  Hua Huang; Juan Wu; Guangfu Jin; Hanze Zhang; Yanbing Ding; Zhaolai Hua; Yan Zhou; Yan Xue; Yan Lu; Zhibin Hu; Yaochu Xu; Hongbing Shen
Journal:  J Biomed Res       Date:  2010-03

10.  Absence of Common Polymorphisms of Toll Like Receptor 4 (TLR4): Asp299Gly, Thr399Ile in Patients with Gastroduodenal Diseases in Japan.

Authors:  Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Ichiro Hirata; Hiroshi Nakano
Journal:  J Clin Biochem Nutr       Date:  2007-01       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.